HOOKIPA Pharma
HOOK
HOOK was delisted on the 7th of August, 2025.
44 hedge funds and large institutions have $25.7M invested in HOOKIPA Pharma in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 12 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.94% less ownership
Funds ownership: 6.05% → 5.12% (-0.94%)
17% less funds holding
Funds holding: 53 → 44 (-9)
36% less capital invested
Capital invested by funds: $40.1M → $25.7M (-$14.4M)
40% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 15
62% less call options, than puts
Call options by funds: $10K | Put options by funds: $26K
67% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$2.67M |
| 2 |
Morgan Stanley
New York
|
+$139K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$104K |
| 4 |
BC
BIT Capital
Berlin,
Germany
|
+$66.6K |
| 5 |
BlackRock
New York
|
+$27.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$1.63M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.08M |
| 3 |
Walleye Capital
New York
|
-$1.01M |
| 4 |
CA
CHI Advisors
New York
|
-$694K |
| 5 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$678K |
HOOK Hedge Fund Activity: Q3 2023 in Review
44 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q3 2023, worth a combined $25.7M — down 36% from $40.1M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of HOOK and 4 opened new positions — a net loss of 8 holders — while 15 trimmed existing stakes and 9 added.
The largest buyer was Baker Bros. Advisors, adding an estimated $2.67M. The largest seller was Redmile Group, cutting an estimated $1.63M.
- 44 institutional investors held HOOKIPA Pharma (HOOK) as of Q3 2023, down from 53 in Q2 2023.
- Funds reported $25.7M of HOOKIPA Pharma stock for Q3 2023, down 36% quarter-over-quarter.
- 4 funds opened new HOOKIPA Pharma positions in Q3 2023 and 12 closed out, a net change of -8 holders.
- The largest HOOKIPA Pharma buyer in Q3 2023 was Baker Bros. Advisors, an estimated $2.67M added.
- The largest HOOKIPA Pharma seller in Q3 2023 was Redmile Group, an estimated $1.63M sold.
Based on aggregated 13F filings for Q3 2023.